Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors.
Bennouna J, Levy V, Sicard H, Senellart H, Audrain M, Hiret S, Rolland F, Bruzzoni-Giovanelli H, Rimbert M, Galéa C, Tiollier J, Calvo F.
Bennouna J, et al. Among authors: tiollier j.
Cancer Immunol Immunother. 2010 Oct;59(10):1521-30. doi: 10.1007/s00262-010-0879-0. Epub 2010 Jun 19.
Cancer Immunol Immunother. 2010.
PMID: 20563721
Free PMC article.
Clinical Trial.